Health Care International - TheraGenetics Announces Agreement With King's College London To Participate In AddNeuroMed Consortium To Identify Biomarkers For Alzheimer's Disease
TheraGenetics Limited, a personalized medicine diagnostics company that is developing and commercializing a portfolio of pharmacogenetic diagnostic tests to guide and improve the treatment of central nervous system (CNS) disorders, announced an agre
Comments